Gemma Jacklyn
YOU?
Author Swipe
View article: The management of women with ductal carcinoma in situ of the breast in Australia and New Zealand between 2007 and 2016
The management of women with ductal carcinoma in situ of the breast in Australia and New Zealand between 2007 and 2016 Open
Background The incidence of detected ductal carcinoma in situ (DCIS) continues to increase and now accounts for 14% of all breast cancer, and 20%–25% of screen‐detected cases. Treatment trends of DCIS are important in order to inform the o…
View article: Informing Women About Overdetection in Breast Cancer Screening: Two-Year Outcomes From a Randomized Trial
Informing Women About Overdetection in Breast Cancer Screening: Two-Year Outcomes From a Randomized Trial Open
Background Supporting well-informed decisions about breast cancer screening requires communicating that inconsequential disease may be detected, leading to overdiagnosis and overtreatment. Having previously shown that telling women about o…
View article: Impact of Full-Field Digital Mammography Versus Film-Screen Mammography in Population Screening: A Meta-Analysis
Impact of Full-Field Digital Mammography Versus Film-Screen Mammography in Population Screening: A Meta-Analysis Open
Background Breast screening programs replaced film mammography with digital mammography, and the effects of this practice shift in population screening on health outcomes can be measured through examination of cancer detection and interval…
View article: Women’s Acceptance of Overdetection in Breast Cancer Screening: Can We Assess Harm-Benefit Tradeoffs?
Women’s Acceptance of Overdetection in Breast Cancer Screening: Can We Assess Harm-Benefit Tradeoffs? Open
Background. Breast cancer screening has been presented to women as mostly positive for decades, despite voices raising issues related to harms since its introduction. Public communications about breast cancer screening tended to use persua…
View article: Overdiagnosis due to screening mammography for women aged 40 years and over
Overdiagnosis due to screening mammography for women aged 40 years and over Open
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effect of screening mammography for breast cancer on overdiagnosis in women aged 40 years and older at average risk of breast cancer.
View article: How information about overdetection changes breast cancer screening decisions: a mediation analysis within a randomised controlled trial
How information about overdetection changes breast cancer screening decisions: a mediation analysis within a randomised controlled trial Open
Objectives In a randomised controlled trial, we found that informing women about overdetection changed their breast screening decisions. We now present a mediation analysis exploring the psychological pathways through which study participa…
View article: Assessing the efficacy of cancer screening
Assessing the efficacy of cancer screening Open
Background:Population-based cancer screening has been established for several types of cancer in Australia and internationally. Screening may perform differently in practice from randomised controlled trials, which makes evaluating program…
View article: Impact of extending screening mammography to older women Information to support informed choices
Impact of extending screening mammography to older women Information to support informed choices Open
From 2013 through 2017, the Australian national breast cancer screening programme is gradually inviting women aged 70–74 years to attend screening, following a policy decision to extend invitations to older women. We estimate the benefits …
View article: Meta-analysis of breast cancer mortality benefit and overdiagnosis adjusted for adherence: improving information on the effects of attending screening mammography
Meta-analysis of breast cancer mortality benefit and overdiagnosis adjusted for adherence: improving information on the effects of attending screening mammography Open
Adjustment for nonadherence increased the size of the mortality benefit and risk of overdiagnosis by up to 50%. These estimates are more appropriate when developing quantitative information to support individual decisions about attending s…